Lovastatin
Product Images NDC 70934-755

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 70934-755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 755 90 Master Bottle Label Approval Rev A 05 20)

Lovastatin Tablets USP 10 mg label from Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label indicates a package of 90 tablets for prescription use. Storage instructions specify 20°-25°C controlled room temperature and protection from light. The label includes lot, expiration, and NDC number 70934-755-90.*

FDA Label Image

Lovastatin Structural Formula (Image 1)

Chemical structure of lovastatin, showing its molecular arrangement with multiple rings, hydroxyl, and ketone functional groups.*

FDA Label Image

Figure 1: Actue Major Coronary Events (primary Endpoint) (Image 2)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' comparing the proportion of participants without event over years of follow-up between Lovastatin and placebo groups. The graph shows a 37% risk reduction favoring Lovastatin with statistical significance (p < 0.001).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.